There is a newer version of this record available.

Working paper Open Access

Ivermectin for Covid-19

Sparavigna, Amelia Carolina

Discussion of scholar papers published until June 28, 2020,  on Ivermectin, and of news that we can find about its use for Covid-19.  A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv,  which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19.  From news, we consider in particular the case of Iquitos,  capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. 

Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.
Files (215.4 kB)
Name Size
Ivermectin-7.pdf
md5:7e772612565d1d004d6b95deeaf8539c
215.4 kB Download
8,819
3,898
views
downloads
All versions This version
Views 8,819717
Downloads 3,898703
Data volume 1.6 GB151.4 MB
Unique views 6,613621
Unique downloads 3,325641

Share

Cite as